The city wants your opinion on supervised injection sites

As the city considers supervised injection sites in Hamilton, local planners want your opinion about places where drug users can get high under medical supervision.

It’s an idea that has spurred much controversy in Canada, but is also rooted in research that shows harm reduction measures like this one can help save lives, reduce drug use, and improve public safety.

This week, the city launched an online survey of people who live and work in Hamilton about supervised injection sites (also known as safe injection sites).

It runs until Oct. 26, and you can fill it out right here.

“Survey feedback will help inform next steps as the city considers conducting a study to better understand the need in the community and whether [supervised injection sites] would be an effective service to support community and individual health in Hamilton,” the city said in a news release.

At these sites, intravenous drug users can bring in their drugs, and are supplied with clean needles to inject them.

Nurses are also on site to monitor in case of overdose. This would both cut down on overdose deaths, officials say, (there are about 30 in Hamilton each year, and that number is a conservative estimate), as well as help with the spread of bloodborne pathogens.

Officials say the site would also help eliminate used needles strewn around the city’s dark corners and alleyways.

The project is still very much in its early stages. Last month, the board of health approved plans to begin exploring the viability of local safe injection sites through a study.

The approval of that study is contingent on a debate for the 2017 budget, as costs were a sticking point for some councillors.

It would cost $250,000 in next year’s budget for the study. If approved, officials say would cost about $1 million to $1.5 million to set up a safe injection site.

Associate Medical Officer of Health Dr. Jessica Hopkins told council that annual costs are more difficult to predict at this stage.

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below